Quantcast
Last updated on April 18, 2014 at 10:24 EDT

Latest hypoglycemia Stories

2012-05-09 14:24:37

'Diabetes Insulin Guidance System' automatically updates weekly insulin dosage for better glycemic control, fewer hypoglycemic events Newly published results from a clinical study of the Diabetes Insulin Guidance System (DIGS), under development by Hygieia, Inc., demonstrate DIGS' potential to improve blood glucose control for insulin-using patients with type 2 or type 1 diabetes. DIGS automatically adjusted insulin dosage based on each individual's reported blood glucose results. Over the...

2012-05-03 02:31:16

THE WOODLANDS, Texas, May 3, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that an independent, non-profit organization will provide funding to support the Phase 2 development of LX4211 in type 1 diabetes. LX4211, a dual inhibitor of sodium glucose transporter 1 and 2 (SGLT1 and SGLT2), was designed to improve control of blood glucose through mechanisms that do not require the pancreas to produce insulin. In type 1 diabetes, also called...

2012-04-16 06:25:37

INDIANAPOLIS, April 16, 2012 /PRNewswire/ -- Lilly Diabetes and Walgreens are educating people living with diabetes about one of the most common and misunderstood consequences of diabetes: hypoglycemia (low blood sugar). The companies today launched an awareness campaign at 43 Walgreens pharmacies throughout the Indianapolis area. Lilly Diabetes will provide take-home educational materials about hypoglycemia that pharmacists may use when counseling people with diabetes. Hypoglycemia occurs...

2012-04-03 11:38:15

Doctors are more reluctant to start their patients on insulin than the patients are themselves, according to a new study led by researchers at St. Michael's Hospital. "It is well-known that insulin is effective in lowering blood sugar," said Dr. Catherine Yu, a researcher at the hospital's Keenan Research Centre and senior author of the paper. "But there are no clear recommendations on the safest and most effective way to start patients on it, and so physicians are often hesitant to do...

2012-04-03 05:32:24

By Rhonda Craig, Ivanhoe Health Correspondent GAINESVILLE, Fla. (Ivanhoe Newswire) --Every year an estimated six million U.S. hospitalizations are accompanied by hyperglycemia, a condition that occurs when your blood sugar is too high. While the condition is often associated with diabetes; as many as 1.5 million hospitalized patients with significant hyperglycemia have no history of diabetes. Controlling blood sugar levels in the hospital can be a life or death matter. Hyperglycemia is a...

2012-04-02 02:28:55

PRINCETON, N.J., April 2, 2012 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, announced today that the U.S. Food and Drug Administration (FDA) has approved Levemir(®) (insulin detemir [rDNA origin] injection) for a pregnancy Category B classification, indicating that Levemir(®), when used in pregnant women with diabetes, did not increase the risk of harm to the unborn baby. To view the multimedia assets associated with this release, please click:...

2012-03-25 23:01:11

Respected stress expert James L. Wilson DC, ND, PhD is invited by the Australasian Academy of Anti-Ageing Medicine to present medical lecture to Australian physicians with new solutions for stress-related depression, adrenal fatigue, and metabolic syndrome (PRWEB) March 24, 2012 The complex 21st century stress overload from economic, environmental, social and psychological factors has far-reaching effects on health worldwide. A 2007 study performed by The Foundation for Integrated Research...

2012-03-20 22:20:41

BRUSSELS, March 21, 2012 /PRNewswire/ -- OptiScan Biomedical Corporation, a developer of innovative continuous glucose monitoring systems for use in intensive care units (ICU), announced positive clinical study data for the OptiScanner(TM), the company's first-of-its-kind automated, bedside glucose monitoring system. Study results demonstrated excellent clinical accuracy for the OptiScanner in monitoring the blood glucose levels of critically ill patients in severely ill ICU patients....

2012-03-08 15:51:25

XOMA Corporation (Nasdaq: XOMA) announced that its study of XMetA, the company's fully-human allosteric monoclonal antibody to the insulin receptor, is available online and will be published in the May issue of the American Diabetes Association's journal Diabetes. XMetA is the first antibody specific for the insulin receptor shown to correct hyperglycemia in a mouse model of diabetes. Results of a study conducted by XOMA and confirmed by investigators at the University of California, San...

2012-02-28 10:31:53

University of Michigan leads study showing TAK-875 helps control blood sugar in type 2 diabetes by boosting insulin TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study. The results of the phase 2 randomized trial were published Online First Sunday in The Lancet. Type 2 diabetes is the most common...


Latest hypoglycemia Reference Libraries

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (1 articles) »